Search

Author/Creator Roth, Eli

1. Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placebo. Issue 1 (December 2016)

Authors:
Toth, Peter; Hamon, Sara; Jones, Steven; Martin, Seth; Joshi, Parag; Kulkarni, Krishnaji; Banerjee, Poulabi; Hanotin, Corinne; Roth, Eli; McKenney, James
Journal:
Lipids in health and disease
Issue:
Volume 15:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome. Issue 1 (14th October 2016)

Authors:
Blom, Dirk J.; Koren, Michael J.; Roth, Eli; Monsalvo, Maria Laura; Djedjos, C. Stephen; Nelson, Patric; Elliott, Mary; Wasserman, Scott M.; Ballantyne, Christie M.; Holman, Rury R.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 19:Issue 1(2017)
Page Start:
98
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: A multicenter FDG-PET trial. Issue 2 (June 2015)

Authors:
Emami, Hamed; Vucic, Esad; Subramanian, Sharath; Abdelbaky, Amr; Fayad, Zahi A.; Du, Shuyan; Roth, Eli; Ballantyne, Christie M.; Mohler, Emile R.; Farkouh, Michael E.; Kim, Joonyoung; Farmer, Matthew; Li, Li; Ehlgen, Alexander; Langenickel, Thomas H.; Velasquez, Linda; Hayes, Wendy; Tawakol, Ahmed
Journal:
Atherosclerosis
Issue:
Volume 240:Issue 2(2015)
Page Start:
490
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗